Toggle navigation
Home
Search
Services
Blog
Contact
About
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W.
Kadmus Pharmaceuticals, Inc., Irvine, CA, United States
Search 32 grants from Kelvin Gee
Search grants from Kadmus Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of Cathelicidin in Intestinal Inflammation
Hedgehog signaling and organogenesis of the limb
Perception of the Muslim Community on Genomic Medicine
Behavioral Regulation of Neuroendocrine Cells
Development of Specific Neuronal Connections
Recently added grants:
dsRNA regulation of the cytosolic innate immune system
Administrative Core
Designer covalent heterobivalent inhibitors to prevent IgE-dependent allergic reactions
Outer Membrane Vesicles (OMVs) and Proteomics
Host Response Monitoring
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
1R41MH060527-01A1
Application #
6134497
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Murphy, Diane
Project Start
2000-06-01
Project End
2002-05-31
Budget Start
2000-06-01
Budget End
2002-05-31
Support Year
1
Fiscal Year
2000
Total Cost
$120,208
Indirect Cost
Institution
Name
Kadmus Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Irvine
State
CA
Country
United States
Zip Code
92612
Related projects
NIH 2001
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$7,023
NIH 2000
R41 MH
Identifying Ligands for A Novel Gabaa Receptor Subtype
Gee, Kelvin W. / Kadmus Pharmaceuticals, Inc.
$120,208
Comments
Be the first to comment on this grant